PFE - Small Biotech Promosome Drops Lawsuit Against Pfizer BioNTech in COVID-19 Vaccine Patent Dispute | Benzinga
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infringement related to messenger RNA technology.
However, the financial terms of the agreement were not disclosed.
This development follows Promosome's earlier decision to drop a similar lawsuit against COVID-19 vaccine producer Moderna Inc (NASDAQ: MRNA).
In June, Promosome initiated legal action against Pfizer, BioNTech, and Moderna, alleging that these companies had copied its technology ...